The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants
Clinical trial NCT00000961 · TERMINATED
Trial details
- NCT number
- NCT00000961
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Primary completion
- 1991-05-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.